Black Dog Institute, Randwick, Australia.
School of Psychiatry, Faculty of Medicine, University of New South Wales Sydney, Kensington, Australia.
J Med Internet Res. 2022 Sep 21;24(9):e38497. doi: 10.2196/38497.
Shift is a novel smartphone app for providing a digital-first mental health resource to junior doctors. It contains psychoeducational material, cognitive behavioral modules, guided mediations, information on common work stressors, and a section on help-seeking options for psychological problems through workplace and private avenues.
This study aimed to conduct a preliminary investigation of the use and potential effectiveness of Shift on depressive and anxiety symptoms (primary outcomes) and work and social functioning, COVID-19 safety concerns, and help seeking (secondary outcomes). This study also sought feedback on whether Shift was seen as an acceptable tool.
Junior doctors in New South Wales, Australia, were approached through promotional activities from the Ministry of Health, specialist medical colleges, and social media advertisements between June and August 2020. Consenting participants provided web-based baseline data, used the Shift app for 30 days, and were asked to complete a poststudy web-based questionnaire. Outcomes were analyzed under the intention-to-treat principle.
A total of 222 (n=156 female, 70.3%; mean age 29.2, SD 4.61 years) junior doctors provided full baseline data. Of these, 89.2% (198/222) downloaded the app, logged into the app approximately 6 times (mean 5.68, SD 7.51), completed 4 in-app activities (mean 3.77, SD 4.36), and spent a total of 1 hour on in-app activities (mean 52:23, SD 6:00:18) over 30 days. Postintervention and app use data were provided by 24.3% (54/222) of participants. Depressive and anxiety symptoms significantly decreased between the pre- and postassessment points as expected; however, physicians' COVID-19 safety concerns significantly increased. Work and social functioning, COVID-19 concerns for family and friends, and help seeking did not change significantly. There was no significant relationship between symptom changes and app use (number of log-ins, days between first and last log-in, and total activity time). Most poststudy completers (31/54, 57%) rated Shift highly or very highly.
Despite high levels of nonresponse to the poststudy assessment and increases in COVID-19 safety concerns, junior doctors who used the app reported some improvements in depression and anxiety, which warrant further exploration in a robust manner.
Shift 是一款新颖的智能手机应用程序,旨在为初级医生提供数字化的心理健康资源。它包含心理教育材料、认知行为模块、引导冥想、常见工作压力源信息,以及通过工作场所和私人途径寻求心理问题帮助的选项部分。
本研究旨在初步调查 Shift 在抑郁和焦虑症状(主要结局)以及工作和社交功能、COVID-19 安全问题和寻求帮助(次要结局)方面的使用情况和潜在效果。本研究还征求了关于 Shift 是否被视为一种可接受工具的反馈。
2020 年 6 月至 8 月期间,通过卫生部、专业医学院校和社交媒体广告向澳大利亚新南威尔士州的初级医生开展推广活动,邀请他们参与研究。同意参与的参与者提供了在线基线数据,使用 Shift 应用程序 30 天,并被要求完成在线研究后问卷调查。结果根据意向治疗原则进行分析。
共有 222 名(156 名女性,70.3%;平均年龄 29.2,标准差 4.61 岁)初级医生提供了完整的基线数据。其中,89.2%(198/222)下载了应用程序,平均登录应用程序约 6 次(平均 5.68,标准差 7.51),完成 4 项应用程序内活动(平均 3.77,标准差 4.36),在 30 天内总共花费 1 小时进行应用程序内活动(平均 52:23,标准差 6:00:18)。222 名参与者中有 24.3%(54/222)提供了干预后和应用程序使用数据。如预期的那样,抑郁和焦虑症状在预评估和后评估点之间显著下降;然而,医生对 COVID-19 的安全担忧显著增加。工作和社交功能、COVID-19 对家人和朋友的担忧以及寻求帮助没有显著变化。症状变化与应用程序使用(登录次数、首次和最后一次登录之间的天数以及总活动时间)之间没有显著关系。大多数完成研究后评估的参与者(31/54,57%)对 Shift 给予高度或非常高度的评价。
尽管对研究后评估的反应率较低,且 COVID-19 安全问题有所增加,但使用该应用程序的初级医生报告抑郁和焦虑症状有所改善,这需要以更有力的方式进一步探索。